Improving HPV vaccination rates among adolescents
Official title: The STOP-HPV Scale-Up Study
Funded at University of California Los Angeles · NIH-11058382 · Data updated 2026-11-12
This study is all about helping doctors talk to parents better about the HPV vaccine so that more teens aged 13-17 can get vaccinated, making it easier for families to understand and feel good about the shot.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | April 1, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $552,668 |
| NIH project number | 5R01CA276151-03 |
| Project ID | NIH-11058382 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adolescents aged 13-17 who are eligible for the HPV vaccine and their parents who may have concerns about vaccination.
✕Less likely to help
Patients who are older than 17 years or those who have already completed the HPV vaccination series may not benefit from this research.
What this research studies
This research focuses on increasing the HPV vaccination rates among adolescents aged 13-17 by addressing barriers related to clinician communication and office systems. It involves training clinicians on effective communication techniques to alleviate parental vaccine hesitancy and implementing workflow changes in primary care practices. The study will adapt two promising strategies for deployment by health systems, aiming to enhance the overall vaccination process. By partnering with health systems and using a mixed-methods approach, the research seeks to evaluate the effectiveness of these strategies in real-world settings.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates, thereby reducing the incidence of HPV-related cancers in adolescents.
How similar studies have gone: Previous research has shown success in improving vaccination rates through clinician training and system-level changes, indicating that this approach has potential for effectiveness.
Where this research is happening
-
University of California Los Angeles
Los Angeles, United States Active
Researchers
- Principal investigator: Szilagyi, Peter G — University of California Los Angeles
- Study coordinator: Szilagyi, Peter G
Related research
Other NIH-funded projects on the same topics.
-
Understanding how genetic changes in blood cells relate to heart disease in people with HIV
A study will look at how age-related blood cell mutations and large chromosomal changes might contribute to heart disease risk in people living with HIV.
-
Systems genetics of vascular smooth muscle phenotypes in heart disease
Aims to understand how genetic differences influence vascular smooth muscle cells to improve prevention and treatment of coronary artery disease.
-
Motivation for Alcohol Use in Humans and How It Can Be Measured
This grant explores how people are motivated to drink alcohol and tests a safe, controlled way to study that motivation to inform better treatments for alcohol use disorder.
-
Overcoming CAR T cell resistance with tumor-targeted IL-12 to boost anti-tumor immunity
Aims to make CAR T cell therapy work better for solid tumors by using tumor-focused IL-12 to boost the body’s attack on cancer.
-
PediCODE: A Biorepository and Consortium for CoDE - Congenital Diarrhea and Enteropathy
A nationwide effort to collect clinical data and patient-derived samples to uncover the genetic causes of congenital diarrhea and enteropathy and to build a resource that helps researchers study these diseases.
-
Mentor Moms+: a community-led plan to cut alcohol use and HIV risk during pregnancy in South Africa
A community-based program adapts a trusted peer-led model to help pregnant and lactating people reduce alcohol use and HIV risk in South Africa.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.